A RANDOMIZED, CONTROLLED PHASE III TRIAL OF SORAFENIB WITH OR WITHOUT CONVENTIONAL TRANSARTERIAL CHEMOEMBOLIZATION IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA (STAH)

被引：2
|
作者：
Park, J. -W. [1 ]
Kim, Y. J. [2 ]
Kim, D. Y. [3 ]
Bae, S. H. [4 ]
Yeon, J. E. [5 ]
Han, S. Y. [6 ]
Hwang, J. S. [7 ]
Lee, Y. -J. [8 ]
Cheong, J. Y. [9 ]
Kwon, O. S. [10 ]
Kim, H. Y. [11 ]
Lee, H. C. [12 ]
Heo, J. [13 ]
Kim, B. H. [1 ]
Paik, S. W. [14 ]
机构：
[1] Natl Canc Ctr, Goyang, South Korea
[2] Seoul Natl Univ Hosp, Seoul 110744, South Korea
[3] Severance Hosp, Seoul, South Korea
[4] Catholic Univ Hosp Korea, Seoul, South Korea
[5] Korea Univ, Guro Hosp, Seoul, South Korea
[6] Dong A Univ, Med Ctr, Busan, South Korea
[7] Keimyung Univ, Dongsan Med Ctr, Daegu, South Korea
[8] Busan Paik Hosp, Busan, South Korea
[9] Ajou Univ Hosp, Suwon, South Korea
[10] Gachon Univ, Gil Hosp, Inchon, South Korea
[11] Boramae Med Ctr, Seoul, South Korea
[12] Asan Med Ctr, Seoul, South Korea
[13] Busan Natl Univ Hosp, Busan, South Korea
[14] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
来源：
JOURNAL OF HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
10.1016/S0168-8278(15)31514-2
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P1335
引用
收藏
页码：S857 / S857
页数：1
相关论文
共 50 条
  • [21] Transarterial chemoembolization with miriplatin vs. epirubicin for unresectable hepatocellular carcinoma: a phase III randomized trial
    Ikeda, Masafumi
    Kudo, Masatoshi
    Aikata, Hiroshi
    Nagamatsu, Hiroaki
    Ishii, Hiroshi
    Yokosuka, Osamu
    Torimura, Takuji
    Morimoto, Manabu
    Ikeda, Kenji
    Kumada, Hiromitsu
    Sato, Tosiya
    Kawai, Ikuko
    Yamashita, Toru
    Horio, Hiroshi
    Okusaka, Takuji
    JOURNAL OF GASTROENTEROLOGY, 2018, 53 (02) : 281 - 290
  • [22] Transarterial chemoembolization with miriplatin vs. epirubicin for unresectable hepatocellular carcinoma: a phase III randomized trial
    Masafumi Ikeda
    Masatoshi Kudo
    Hiroshi Aikata
    Hiroaki Nagamatsu
    Hiroshi Ishii
    Osamu Yokosuka
    Takuji Torimura
    Manabu Morimoto
    Kenji Ikeda
    Hiromitsu Kumada
    Tosiya Sato
    Ikuko Kawai
    Toru Yamashita
    Hiroshi Horio
    Takuji Okusaka
    Journal of Gastroenterology, 2018, 53 : 281 - 290
  • [23] Sorafenib plus hepatic arterial infusion of oxaliplatin and fluorouracil vs sorafenib plus transarterial chemoembolization for advanced hepatocellular carcinoma: A biomolecular exploratory, randomized, phase III trial (SHATA-001).
    Lai, Zhicheng
    Kan, Anna
    He, Minke
    Du, Zefeng
    Shi, Ming
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [24] Phase II study of concurrent transarterial chemoembolization and sorafenib in patients with unresectable hepatocellular carcinoma
    Park, Joong-Won
    Koh, Young Hwan
    Kim, Hyun Beom
    Kim, Hwi Young
    An, Sangbu
    Choi, Joon-Il
    Woo, Sang Myung
    Nam, Byung-Ho
    JOURNAL OF HEPATOLOGY, 2012, 56 (06) : 1336 - 1342
  • [25] Transarterial chemoembolization with/without cryotherapy is associated with improved clinical outcomes of sorafenib for the treatment of advanced hepatocellular carcinoma
    Wang, Chunping
    Lu, Yinying
    Wang, Hong
    Gao, Xudong
    Bai, Wenlin
    Qu, Jianhui
    Xu, Guilin
    Zhang, Zhenzhen
    Zeng, Zhen
    Zhou, Lin
    An, Linjing
    Lv, Jiyun
    Yang, Yongping
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2012, 4 (02) : 188 - 196
  • [26] Transarterial infusion chemotherapy alone versus transarterial chemoembolization for the treatment of hepatocellular carcinoma: Results of a multicenter randomized phase III trial
    Okusaka, T.
    Sato, T.
    Hinotsu, S.
    Shioyama, Y.
    Kasugai, H.
    Tanaka, K.
    Kudo, M.
    Saisho, T.
    Osaki, Y.
    Sata, M.
    Fujiyama, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [27] Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH)
    Peng, Zhenwei
    Fan, Wenzhe
    Zhu, Bowen
    Wang, Guoying
    Sun, Junhui
    Xiao, Chengjiang
    Huang, Fuxi
    Tang, Rong
    Cheng, Yu
    Huang, Zhen
    Liang, Yuchuang
    Fan, Huishuang
    Qiao, Liangliang
    Li, Fuliang
    Zhuang, Wenquan
    Peng, Baogang
    Wang, Jiping
    Li, Jiaping
    Kuang, Ming
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (01) : 117 - +
  • [28] The Impact of Combined Transarterial Chemoembolization on the Overall Survival of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib
    Chen, Lufeng
    Su, Hongying
    Shao, Haibo
    Xu, Ke
    Liang, Songnian
    Liu, Ling
    HEPATO-GASTROENTEROLOGY, 2014, 61 (131) : 802 - 808
  • [29] A Prospective, Randomized, Controlled Trial of Preoperative Transarterial Chemoembolization for Resectable Large Hepatocellular Carcinoma
    Zhou, Wei-Ping
    Lai, Eric C. H.
    Li, Ai-Jun
    Fu, Si-Yuan
    Zhou, Jian-Ping
    Pan, Ze-Ya
    Lau, Wan Yee
    Wu, Meng-Chao
    ANNALS OF SURGERY, 2009, 249 (02) : 195 - 202
  • [30] The Efficacy of Transarterial Chemoembolization plus Apatinib or Sorafenib in the Treatment of Advanced Hepatocellular Carcinoma
    Chen, Lei
    Sun, Tao
    Wu, Linxia
    Zhang, Weihua
    Ren, Yanqiao
    Xiang, Dongqiao
    Liang, Bin
    Zheng, Chuansheng
    JOURNAL OF ONCOLOGY, 2021, 2021
12345